rosiglitazone has been researched along with Diarrhea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajwa, PJ; Lee, JW; Lytle, C; Straus, DS | 1 |
| Li, XJ; Liu, CQ; Wang, LY; Yan, B; Yang, SY; Yu, YX; Zhang, HJ; Zhang, SH; Zhang, W | 1 |
1 review(s) available for rosiglitazone and Diarrhea
| Article | Year |
|---|---|
Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis.
Topics: Dehydroepiandrosterone Sulfate; Diarrhea; Female; Humans; Hypoglycemic Agents; Metformin; Nausea; Pioglitazone; Polycystic Ovary Syndrome; Randomized Controlled Trials as Topic; Rosiglitazone; Testosterone; Thiazolidinediones; Time Factors; Treatment Outcome; Triglycerides | 2011 |
1 other study(ies) available for rosiglitazone and Diarrhea
| Article | Year |
|---|---|
Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion.
Topics: Administration, Oral; Animals; Calcium; Carbachol; Chlorides; Cholera Toxin; Colforsin; Colon; Cyclic AMP; Cystic Fibrosis Transmembrane Conductance Regulator; Diarrhea; Disease Models, Animal; Electric Impedance; Female; Gastrointestinal Agents; HT29 Cells; Humans; Ileum; Intermediate-Conductance Calcium-Activated Potassium Channels; Intestinal Mucosa; Intestinal Secretions; Intestines; Jejunum; KCNQ1 Potassium Channel; Mice; Pioglitazone; PPAR gamma; Rosiglitazone; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 2; Thiazolidinediones; Time Factors | 2009 |